Do analysts prefer ACB or CRON?

Cronos Group has a consensus target price of $2.30, suggesting a potential downside of 14.81%. Given Cronos Group's stronger consensus rating and higher possible upside, analysts plainly believe Cronos Group is more favorable than Aurora Cannabis. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aurora Cannabis 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Cronos Group 1 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.20

Do analysts prefer CGC or CRON?

Cronos Group has a consensus price target of $2.30, suggesting a potential downside of 14.81%. Given Cronos Group's stronger consensus rating and higher possible upside, analysts clearly believe Cronos Group is more favorable than Canopy Growth. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Canopy Growth 1 Sell rating(s) 3 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.17 Cronos Group 1 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.20

Does the media prefer CGC or CRON?

In the previous week, Canopy Growth had 6 more articles in the media than Cronos Group. MarketBeat recorded 9 mentions for Canopy Growth and 3 mentions for Cronos Group. Cronos Group's average media sentiment score of 0.71 beat Canopy Growth's score of 0.12 indicating that Cronos Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Canopy Growth 2 Very Positive mention(s) 3 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Cronos Group 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer CRON or OGI?

Cronos Group currently has a consensus target price of $2.30, indicating a potential downside of 14.81%. Given Cronos Group's higher probable upside, research analysts clearly believe Cronos Group is more favorable than Organigram Global. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cronos Group 1 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.20 Organigram Global 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33

Which has better earnings and valuation, CRON or SNDL?

Cronos Group has higher earnings, but lower revenue than SNDL. SNDL is trading at a lower price-to-earnings ratio than Cronos Group, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Cronos Group $146.59M 6.87 -$9.45M $0.01 270.00 SNDL $937.39M 0.39 -$11.29M -$0.03 N/A

Is CRON or SNDL more profitable?

Cronos Group has a net margin of -1.14% compared to SNDL's net margin of -1.19%. SNDL's return on equity of -1.02% beat Cronos Group's return on equity. Company Net Margins Return on Equity Return on Assets Cronos Group -1.14% -1.26% -1.20% SNDL -1.19% -1.02% -0.85%

Does the media refer more to CRON or SNDL?

In the previous week, Cronos Group had 2 more articles in the media than SNDL. MarketBeat recorded 3 mentions for Cronos Group and 1 mentions for SNDL. Cronos Group's average media sentiment score of 0.71 beat SNDL's score of 0.00 indicating that Cronos Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cronos Group 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SNDL 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media refer more to CRON or TLRY?

In the previous week, Tilray Brands had 18 more articles in the media than Cronos Group. MarketBeat recorded 21 mentions for Tilray Brands and 3 mentions for Cronos Group. Cronos Group's average media sentiment score of 0.71 beat Tilray Brands' score of 0.64 indicating that Cronos Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cronos Group 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Tilray Brands 9 Very Positive mention(s) 4 Positive mention(s) 8 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Cronos Group (CRON) Competitors

$2.70 +0.05 (+1.89%)

Closing price 03:58 PM Eastern

Extended Trading

$2.68 -0.02 (-0.89%)

As of 07:56 PM Eastern

Compare

CRON vs. ACB, CGC, OGI, SNDL, and TLRY

Should you buy Cronos Group stock or one of its competitors? MarketBeat compares Cronos Group with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Cronos Group include Aurora Cannabis (ACB), Canopy Growth (CGC), Organigram Global (OGI), SNDL (SNDL), and Tilray Brands (TLRY). These companies are all part of the "pharmaceutical products" industry.

How does Cronos Group compare to Aurora Cannabis?

Aurora Cannabis (NASDAQ:ACB) and Cronos Group (NASDAQ:CRON) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, earnings, dividends, risk, valuation, analyst recommendations, institutional ownership and media sentiment.

Cronos Group has a net margin of -1.14% compared to Aurora Cannabis' net margin of -33.57%. Aurora Cannabis' return on equity of 0.10% beat Cronos Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Aurora Cannabis	-33.57%	0.10%	0.07%
Cronos Group	-1.14%	-1.26%	-1.20%

Cronos Group has a consensus target price of $2.30, suggesting a potential downside of 14.81%. Given Cronos Group's stronger consensus rating and higher possible upside, analysts plainly believe Cronos Group is more favorable than Aurora Cannabis.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aurora Cannabis	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Cronos Group	1 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.20

In the previous week, Cronos Group had 3 more articles in the media than Aurora Cannabis. MarketBeat recorded 3 mentions for Cronos Group and 0 mentions for Aurora Cannabis. Cronos Group's average media sentiment score of 0.71 beat Aurora Cannabis' score of 0.00 indicating that Cronos Group is being referred to more favorably in the news media.

Company	Overall Sentiment
Aurora Cannabis	Neutral
Cronos Group	Positive

Aurora Cannabis has a beta of 0.53, meaning that its stock price is 47% less volatile than the broader market. Comparatively, Cronos Group has a beta of 0.89, meaning that its stock price is 11% less volatile than the broader market.

Cronos Group has lower revenue, but higher earnings than Aurora Cannabis. Aurora Cannabis is trading at a lower price-to-earnings ratio than Cronos Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aurora Cannabis	$247.82M	0.71	-$88.13M	-$1.56	N/A
Cronos Group	$146.59M	6.87	-$9.45M	$0.01	270.00

47.6% of Aurora Cannabis shares are held by institutional investors. Comparatively, 8.7% of Cronos Group shares are held by institutional investors. 0.0% of Aurora Cannabis shares are held by company insiders. Comparatively, 7.8% of Cronos Group shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

Cronos Group beats Aurora Cannabis on 12 of the 16 factors compared between the two stocks.

How does Cronos Group compare to Canopy Growth?

Canopy Growth (NASDAQ:CGC) and Cronos Group (NASDAQ:CRON) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, profitability, earnings, media sentiment, risk, analyst recommendations, institutional ownership and dividends.

Cronos Group has lower revenue, but higher earnings than Canopy Growth. Canopy Growth is trading at a lower price-to-earnings ratio than Cronos Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Canopy Growth	$251.01M	1.52	-$190.29M	-$0.59	N/A
Cronos Group	$146.59M	6.87	-$9.45M	$0.01	270.00

Cronos Group has a consensus price target of $2.30, suggesting a potential downside of 14.81%. Given Cronos Group's stronger consensus rating and higher possible upside, analysts clearly believe Cronos Group is more favorable than Canopy Growth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Canopy Growth	1 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.17
Cronos Group	1 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.20

Canopy Growth has a beta of 0.77, meaning that its stock price is 23% less volatile than the broader market. Comparatively, Cronos Group has a beta of 0.89, meaning that its stock price is 11% less volatile than the broader market.

3.3% of Canopy Growth shares are held by institutional investors. Comparatively, 8.7% of Cronos Group shares are held by institutional investors. 0.2% of Canopy Growth shares are held by insiders. Comparatively, 7.8% of Cronos Group shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Cronos Group has a net margin of -1.14% compared to Canopy Growth's net margin of -75.27%. Cronos Group's return on equity of -1.26% beat Canopy Growth's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Canopy Growth	-75.27%	-26.95%	-17.20%
Cronos Group	-1.14%	-1.26%	-1.20%

In the previous week, Canopy Growth had 6 more articles in the media than Cronos Group. MarketBeat recorded 9 mentions for Canopy Growth and 3 mentions for Cronos Group. Cronos Group's average media sentiment score of 0.71 beat Canopy Growth's score of 0.12 indicating that Cronos Group is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Canopy Growth	2 Very Positive mention(s)	3 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Cronos Group	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Cronos Group beats Canopy Growth on 13 of the 15 factors compared between the two stocks.

How does Cronos Group compare to Organigram Global?

Cronos Group (NASDAQ:CRON) and Organigram Global (NASDAQ:OGI) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, profitability, media sentiment, institutional ownership, dividends, valuation and risk.

Cronos Group has higher earnings, but lower revenue than Organigram Global. Organigram Global is trading at a lower price-to-earnings ratio than Cronos Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cronos Group	$146.59M	6.87	-$9.45M	$0.01	270.00
Organigram Global	$185.07M	0.72	-$17.70M	-$0.13	N/A

Cronos Group has a net margin of -1.14% compared to Organigram Global's net margin of -9.22%. Cronos Group's return on equity of -1.26% beat Organigram Global's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cronos Group	-1.14%	-1.26%	-1.20%
Organigram Global	-9.22%	-13.41%	-9.09%

In the previous week, Cronos Group had 3 more articles in the media than Organigram Global. MarketBeat recorded 3 mentions for Cronos Group and 0 mentions for Organigram Global. Cronos Group's average media sentiment score of 0.71 beat Organigram Global's score of 0.00 indicating that Cronos Group is being referred to more favorably in the media.

Company	Overall Sentiment
Cronos Group	Positive
Organigram Global	Neutral

Cronos Group currently has a consensus target price of $2.30, indicating a potential downside of 14.81%. Given Cronos Group's higher probable upside, research analysts clearly believe Cronos Group is more favorable than Organigram Global.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cronos Group	1 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.20
Organigram Global	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

Cronos Group has a beta of 0.89, indicating that its stock price is 11% less volatile than the broader market. Comparatively, Organigram Global has a beta of 1.43, indicating that its stock price is 43% more volatile than the broader market.

8.7% of Cronos Group shares are owned by institutional investors. Comparatively, 34.6% of Organigram Global shares are owned by institutional investors. 7.8% of Cronos Group shares are owned by insiders. Comparatively, 0.1% of Organigram Global shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

Cronos Group beats Organigram Global on 11 of the 15 factors compared between the two stocks.

How does Cronos Group compare to SNDL?

Cronos Group (NASDAQ:CRON) and SNDL (NASDAQ:SNDL) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their media sentiment, analyst recommendations, earnings, dividends, profitability, institutional ownership, risk and valuation.

Cronos Group has a net margin of -1.14% compared to SNDL's net margin of -1.19%. SNDL's return on equity of -1.02% beat Cronos Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cronos Group	-1.14%	-1.26%	-1.20%
SNDL	-1.19%	-1.02%	-0.85%

In the previous week, Cronos Group had 2 more articles in the media than SNDL. MarketBeat recorded 3 mentions for Cronos Group and 1 mentions for SNDL. Cronos Group's average media sentiment score of 0.71 beat SNDL's score of 0.00 indicating that Cronos Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cronos Group	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
SNDL	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

8.7% of Cronos Group shares are held by institutional investors. 7.8% of Cronos Group shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Cronos Group has a beta of 0.89, indicating that its stock price is 11% less volatile than the broader market. Comparatively, SNDL has a beta of 0.91, indicating that its stock price is 9% less volatile than the broader market.

Cronos Group presently has a consensus price target of $2.30, indicating a potential downside of 14.81%. SNDL has a consensus price target of $5.00, indicating a potential upside of 249.65%. Given SNDL's higher possible upside, analysts plainly believe SNDL is more favorable than Cronos Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cronos Group	1 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.20
SNDL	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Cronos Group has higher earnings, but lower revenue than SNDL. SNDL is trading at a lower price-to-earnings ratio than Cronos Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cronos Group	$146.59M	6.87	-$9.45M	$0.01	270.00
SNDL	$937.39M	0.39	-$11.29M	-$0.03	N/A

Summary

Cronos Group beats SNDL on 11 of the 16 factors compared between the two stocks.

How does Cronos Group compare to Tilray Brands?

Cronos Group (NASDAQ:CRON) and Tilray Brands (NASDAQ:TLRY) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their profitability, institutional ownership, risk, valuation, analyst recommendations, media sentiment, dividends and earnings.

Cronos Group has higher earnings, but lower revenue than Tilray Brands. Tilray Brands is trading at a lower price-to-earnings ratio than Cronos Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cronos Group	$146.59M	6.87	-$9.45M	$0.01	270.00
Tilray Brands	$821.31M	0.65	-$2.19B	-$13.65	N/A

Cronos Group has a beta of 0.89, meaning that its stock price is 11% less volatile than the broader market. Comparatively, Tilray Brands has a beta of 1.88, meaning that its stock price is 88% more volatile than the broader market.

8.7% of Cronos Group shares are held by institutional investors. Comparatively, 9.4% of Tilray Brands shares are held by institutional investors. 7.8% of Cronos Group shares are held by insiders. Comparatively, 0.8% of Tilray Brands shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

In the previous week, Tilray Brands had 18 more articles in the media than Cronos Group. MarketBeat recorded 21 mentions for Tilray Brands and 3 mentions for Cronos Group. Cronos Group's average media sentiment score of 0.71 beat Tilray Brands' score of 0.64 indicating that Cronos Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cronos Group	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Tilray Brands	9 Very Positive mention(s)	4 Positive mention(s)	8 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Cronos Group currently has a consensus target price of $2.30, suggesting a potential downside of 14.81%. Tilray Brands has a consensus target price of $11.50, suggesting a potential upside of 149.46%. Given Tilray Brands' stronger consensus rating and higher possible upside, analysts plainly believe Tilray Brands is more favorable than Cronos Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cronos Group	1 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.20
Tilray Brands	1 Sell rating(s)	4 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.25

Cronos Group has a net margin of -1.14% compared to Tilray Brands' net margin of -156.51%. Cronos Group's return on equity of -1.26% beat Tilray Brands' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cronos Group	-1.14%	-1.26%	-1.20%
Tilray Brands	-156.51%	-3.31%	-2.42%

Summary

Cronos Group beats Tilray Brands on 9 of the 16 factors compared between the two stocks.

Get Cronos Group News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CRON and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CRON vs. The Competition

Export

Metric	Cronos Group	MED Industry	Medical Sector	NASDAQ Exchange
Market Cap	$988.54M	$2.97B	$6.45B	$12.39B
Dividend Yield	N/A	1.80%	2.69%	5.83%
P/E Ratio	270.27	18.43	24.92	23.98
Price / Sales	6.87	336.82	529.01	109.54
Price / Cash	211.38	56.31	44.82	54.51
Price / Book	0.90	4.11	10.79	6.50
Net Income	-$9.45M	$64.45M	$3.56B	$336.88M
7 Day Performance	3.85%	2.24%	1.67%	-0.22%
1 Month Performance	-1.46%	1.04%	0.43%	0.77%
1 Year Performance	44.39%	30.05%	32.84%	31.57%

Cronos Group Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CRON Cronos Group	1.5352 of 5 stars	$2.70 +1.9%	$2.30 -14.8%	+42.5%	$988.54M	$146.59M	270.27	450	News Coverage
ACB Aurora Cannabis	0.3321 of 5 stars	$2.95 -3.0%	N/A	-29.7%	$186.49M	$247.82M	N/A	1,130
CGC Canopy Growth	1.4915 of 5 stars	$0.98 -1.7%	N/A	-22.8%	$404.12M	$225.65M	N/A	3,150	Trending News Insider Trade
OGI Organigram Global	0.5361 of 5 stars	$1.03 -2.8%	N/A	-25.6%	$149.21M	$185.07M	N/A	1,139	High Trading Volume
SNDL SNDL	3.4634 of 5 stars	$1.43 +0.7%	$5.00 +249.7%	+12.0%	$365.50M	$677.32M	N/A	2,751	High Trading Volume

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:CRON) was last updated on 6/23/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Cronos Group (CRON) Competitors

CRON vs. ACB, CGC, OGI, SNDL, and TLRY

How does Cronos Group compare to Aurora Cannabis?

Summary

How does Cronos Group compare to Canopy Growth?

Summary

How does Cronos Group compare to Organigram Global?

Summary

How does Cronos Group compare to SNDL?

Summary

How does Cronos Group compare to Tilray Brands?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CRON vs. The Competition

Cronos Group Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Cronos Group (CRON) Competitors

CRON vs. ACB, CGC, OGI, SNDL, and TLRY

How does Cronos Group compare to Aurora Cannabis?

Is ACB or CRON more profitable?

Do analysts prefer ACB or CRON?

Does the media prefer ACB or CRON?

Which has more risk & volatility, ACB or CRON?

Which has stronger earnings and valuation, ACB or CRON?

Do insiders and institutionals hold more shares of ACB or CRON?

Summary

How does Cronos Group compare to Canopy Growth?

Which has better valuation and earnings, CGC or CRON?

Do analysts prefer CGC or CRON?

Which has more risk and volatility, CGC or CRON?

Do institutionals & insiders hold more shares of CGC or CRON?

Is CGC or CRON more profitable?

Does the media prefer CGC or CRON?

Summary

How does Cronos Group compare to Organigram Global?

Which has stronger valuation & earnings, CRON or OGI?

Is CRON or OGI more profitable?

Does the media refer more to CRON or OGI?

Do analysts prefer CRON or OGI?

Which has more volatility and risk, CRON or OGI?

Do insiders & institutionals believe in CRON or OGI?

Summary

How does Cronos Group compare to SNDL?

Is CRON or SNDL more profitable?

Does the media refer more to CRON or SNDL?

Do insiders and institutionals believe in CRON or SNDL?

Which has more risk & volatility, CRON or SNDL?

Do analysts prefer CRON or SNDL?

Which has better earnings and valuation, CRON or SNDL?

Summary

How does Cronos Group compare to Tilray Brands?

Which has preferable valuation & earnings, CRON or TLRY?

Which has more risk and volatility, CRON or TLRY?

Do insiders and institutionals have more ownership in CRON or TLRY?

Does the media refer more to CRON or TLRY?

Do analysts recommend CRON or TLRY?

Is CRON or TLRY more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CRON vs. The Competition

Cronos Group Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools